LAWSUITS NEWS & LEGAL INFORMATION
Suboxone Tooth Decay Legal News Articles & Interviews
Indivior's Motion to Dismiss Suboxone Lawsuits
December 18, 2024. By Anne Wallace.
Cleveland, OH – On December 16, 2024, Judge J. Philip Calabrese of the Northern District of Ohio heard oral arguments in Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation. The hearing concerned the defendant, Indivior PLC’s, motion to dismiss the Suboxone complaint under Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim on which relief can be granted. The arguments largely tracked briefs originally filed in July 2024, which the court required to be amended.
Read [ Indivior's Motion to Dismiss Suboxone Lawsuits ]
A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision
November 6, 2024. By Anne Wallace.
Cleveland, OH On September 10, 2024, the Northern District of Ohio dismissed claims against Indivior PLC and two Reckitt Benckiser entities in Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation in the multidistrict litigation centralized in the Northern District of Ohio. The court’s decision is a significant setback for individuals who suffered serious Suboxone side effects and dental damage from using the sublingual film form of the drug. They allege that Indivior and other defendants failed to adequately warn about the potential for dental erosion and decay associated with the film's acidic properties.
Read [ A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision ]
Suboxone Tooth Decay MDL – Status Update
October 21, 2024. By Anne Wallace.
Cleveland, OH In recent years, Suboxone, a critical medication used to treat opioid addiction, has come under fire for its unintended side effects—specifically, severe tooth decay. While the drug has helped millions overcome opioid dependence, patients across the country have filed dangerous drug lawsuits claiming that Suboxone caused serious dental problems, leading to painful and costly procedures as well as social isolation for some individuals. These claims have been consolidated in an ongoing multidistrict litigation (MDL) in the Northern District of Ohio, where patients are suing the manufacturers of Suboxone for failing to warn about the risk of tooth decay.
Read [ Suboxone Tooth Decay MDL – Status Update ]
Suboxone Tooth Decay Lawsuits Reflect Only Part of Harm
September 23, 2024. By Anne Wallace.
Cleveland, OH As of September 2024, 674 lawsuits have been consolidated in the multidistrict Suboxone Film Productions liability litigation (MDL) in the Northern District of Ohio. These dangerous drug lawsuits allege that the sublingual film prescribed to treat opioid addiction also caused devastating tooth decay and long-term dental damage. For many patients, this led to costly treatments and a diminished quality of life.
Read [ Suboxone Tooth Decay Lawsuits Reflect Only Part of Harm ]
State AGs Nail $86 Million Suboxone Settlement
August 21, 2024. By Anne Wallace.
New York, NY On July 26, New York Attorney General, Letitia James announced that Suboxone manufacturer Indivior had agreed in principle to pay $86 million to settle Suboxone lawsuits brought by the attorneys general of New York, Illinois, Tennessee, Utah and Virginia. The settlement was reached in coordination with 11 other states. Their dangerous drug lawsuits alleged that Indivior produced and then marketed buprenorphine-based products to dangerous prescribers who, under the guise of “medical treatment,” triggered further harm.
Read [ State AGs Nail $86 Million Suboxone Settlement ]
Suboxone Lawsuit Update
August 8, 2024. By Jane Mundy.
Santa Clara, CA The Suboxone maker had a busy month facing more tooth decay lawsuits, including a Canadian class action.
Read [ Suboxone Lawsuit Update ]
Thousands More Suboxone Lawsuits
June 30, 2024. By Jane Mundy.
Santa Clara, CA Just days before the Suboxone deadline to file, thousands of new Suboxone dental injury plaintiffs--many of whom have likely suffered more than tooth loss--have filed complaints against the manufacturers. June 2024 marked the second-year anniversary of a label warning update and potentially marked the statute of limitations on some claims.
Read [ Thousands More Suboxone Lawsuits ]
Suboxone Statute of Limitations
May 16, 2024. By Jane Mundy.
Santa Clara, CA June 2024 marks the two-year anniversary of Suboxone’s statute of limitations deadlines and lawyers predict thousands more Suboxone tooth decay lawsuits will be filed against Indivior Inc., mainly failure to warn about the risk of dental injuries. It is crucial to file a lawsuit against Indivior or other defendants before the statute of limitations passes. If not, plaintiffs may be unable to proceed with a case.
Read [ Suboxone Statute of Limitations ]
Suboxone maker Indivior in Trouble with the Law Again
February 16, 2024. By Jane Mundy.
Santa Clara, CA Suboxone (buprenorphine and naloxone) was first introduced in 2002 for recovering opioid addicts. The dissolvable tablet was helping people on their road to recovery, but the problems began when a Suboxone film version was introduced in 2013, and it took the drugmakers almost a decade to warn consumers of its side effect: decayed teeth. Many people have experienced permanent damage and Suboxone lawsuits indicate that ruined teeth could have been avoided if the manufacturers warned them and the medical community from Suboxone film side effects. And yes, tooth decay is a legitimate injury that can have devastating effects, both physical and emotional.
Read [ Suboxone maker Indivior in Trouble with the Law Again ]